Final funding period approved for CRC/TRR 205

The Collaborative Research Centre/Transregio 205 can continue its successful work: the German Research Foundation (DFG) has approved the third and final funding period. From 2026, our internationally leading consortium will receive funding for a further three and a half years.

With its approval of the final funding phase, the DFG recognises the outstanding scientific achievements of recent years, the high quality of interdisciplinary collaboration across national locations – including the transCampus – and the international visibility of SFB/TRR 205. At the same time, the approval marks an important milestone on the path to further developing new findings from adrenal gland research in a targeted manner and transferring them into medical practice in a sustainable way.

Together, we look forward with great motivation and confidence to the coming years of the SFB/TRR 205 and to successfully completing the work we have begun.